响应的纳米结构立方体:进展和治疗应用
Ishal Miranda1, Biyas Misra1, Manasa Chikballapur Manjunath1
1Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
Advanced pharmaceutical bulletin
|September 9, 2025
概括
随机液晶纳米粒子 (LLCNP),就像立方体一样,提供先进的药物输送. 这些纳米粒子通过控制释放和改善生物可用性来提高治疗效率和减少副作用.
科学领域:
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
背景情况:
- 纳米技术提供先进的药物输送系统,以最大限度地提高治疗效率并最大限度地减少副作用.
- 包括立方体和六体体在内的热液晶纳米粒子 (LLCNP) 正因其独特的分子结构而引起人们的兴趣.
- 立方体可以封装各种类型的药物 (脂性,水性,两性),将它们定位为多功能药物载体.
研究的目的:
- 审查不同类型的立方体,包括刺激响应变体 (pH,温度,光,酶).
- 详细介绍这些先进的立方体体配方的制备方法和治疗应用.
- 突出立方体在向药物递送中的潜力,重点关注生物可用性和受控释放.
主要方法:
- 关于立方体体准备和表征的现有文献的审查.
- 分析不同的刺激响应的立方体体配方.
- 对立方体的治疗应用和药物输送性能的评估.
主要成果:
- 立方体体表现出高表面积,生物相容性和增强的药物保护.
- 已经开发出各种对刺激有反应的立方体体 (pH,温度,光,酶) 进行量身定制的药物释放.
- 立方体显示出优化生物可用性和实现药物控制释放的潜力,以实现有针对性的输送.
结论:
- 立方体体为先进的药物输送系统提供了一个有前途的纳米技术.
- 立方体构成的主要挑战包括稳定性和可扩展性.
- 对立方体的进一步研究可以带来优化的治疗结果和减少副作用.
相关概念视频
Drug Delivery: Overview
1.2K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.2K
Modified-Release Drug Delivery Systems: Overview
197
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
197
Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127


